Global Vinblastinesulphate (CAS 143-67-9) Market Analysis 2013-2018 and Forecast 2019-2024

April 2019 | 76 pages | ID: G61F225AA51EN
99Strategy

Abstracts

SNAPSHOT

Vinblastinesulphate is a white or light yellow amorphous power, which is easily soluble in water. Vinblastine belongs to the group of cancer-fighting medications known as antineoplastics. Vinblastine is used alone or in combination with other antineoplastic medications to treat many different types of cancer including Hodgkin's disease, non-Hodgkin's lymphoma (cancer of the lymph cells), Kaposi's sarcoma, breast cancer, and testicular cancer. It kills cancer cells by interfering with the genetic material DNA, which is necessary for their growth and reproduction.

The global Vinblastinesulphate (CAS 143-67-9) market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Vinblastinesulphate (CAS 143-67-9) by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

• >98% Vinblastinesulphate
• 97-98% Vinblastinesulphate
• Others

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

• Guangzhou Hanfang Pharmaceutical
• Hainan Vinca Biological Medicine Technology
• Guangzhou Person Pharmaceutical
• Hainan Yueyang Biotechnology
• Hubei Honch Pharmaceutical
• Fine Chemicals Corporation
• Hengtengfu Biological Products
• Vinkem

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

• Lymphoma
• Lung Cancer
• Breast & Ovarian Cancer
• Leukemia
• Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

• North America (U.S., Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
• Asia-Pacific (China, India, Japan, Southeast Asia etc.)
• South America (Brazil, Argentina etc.)
• Middle East & Africa (Saudi Arabia, South Africa etc.)

Contents

1 INDUSTRY OVERVIEW

1.1 Vinblastinesulphate (CAS 143-67-9) Industry
  1.1.1 Overview
  1.1.2 Development of Vinblastinesulphate (CAS 143-67-9)
1.2 Market Segment
  1.2.1 Upstream
  1.2.2 Downstream
1.3 Cost Analysis

2 INDUSTRY ENVIRONMENT (PEST ANALYSIS)

2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology

3 VINBLASTINESULPHATE (CAS 143-67-9) MARKET BY TYPE

3.1 By Type
  3.1.1 >98% Vinblastinesulphate
  3.1.2 97-98% Vinblastinesulphate
  3.1.3 Others
3.2 Market Size
3.3 Market Forecast

4 MAJOR COMPANIES LIST

4.VINBLASTINESULPHATE (CAS 143-67-9) GUANGZHOU HANFANG PHARMACEUTICAL (COMPANY PROFILE, SALES DATA ETC.)

4.2 Hainan Vinca Biological Medicine Technology (Company Profile, Sales Data etc.)
4.3 Guangzhou Person Pharmaceutical (Company Profile, Sales Data etc.)
4.4 Hainan Yueyang Biotechnology (Company Profile, Sales Data etc.)
4.5 Hubei Honch Pharmaceutical (Company Profile, Sales Data etc.)
4.6 Fine Chemicals Corporation (Company Profile, Sales Data etc.)
4.7 Hengtengfu Biological Products (Company Profile, Sales Data etc.)
4.8 Vinkem (Company Profile, Sales Data etc.)

5 MARKET COMPETITION

5.1 Company Competition
5.2 Regional Market by Company

6 DEMAND BY END MARKET

6.1 Demand Situation
  6.1.1 Demand in Lymphoma
  6.1.2 Demand in Lung Cancer
  6.1.3 Demand in Breast & Ovarian Cancer
  6.1.4 Demand in Leukemia
  6.1.5 Demand in Others
6.2 Regional Demand Comparison
6.3 Demand Forecast

7 REGION OPERATION

7.1 Regional Production
7.2 Regional Market
7.3 by Region
  7.3.1 North America
    7.3.1.1 Overview
    7.3.1.2 by Country (U.S., Canada, Mexico)
  7.3.2 Europe
    7.3.2.1 Overview
    7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  7.3.3 Asia-Pacific
    7.3.3.1 Overview
    7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  7.3.4 South America
    7.3.4.1 Overview
    7.3.4.2 by Country (Brazil, Argentina etc.)
  7.3.5 Middle East & Africa
    7.3.5.1 Overview
    7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
7.4 Regional Import & Export
7.5 Regional Forecast

8 MARKETING & PRICE

8.1 Price and Margin
  8.1.1 Price Trends
  8.1.2 Factors of Price Change
  8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel

9 RESEARCH CONCLUSION

List Of Tables

LIST OF TABLES

Table Upstream Segment of Vinblastinesulphate (CAS 143-67-9)
Table Application Segment of Vinblastinesulphate (CAS 143-67-9)
Table Global Vinblastinesulphate (CAS 143-67-9) Market 2013-2024, by Application, in USD Million
Table Major Company List of >98% Vinblastinesulphate
Table Major Company List of 97-98% Vinblastinesulphate
Table Major Company List of Others
Table Global Vinblastinesulphate (CAS 143-67-9) Market 2013-2018, by Type, in USD Million
Table Global Vinblastinesulphate (CAS 143-67-9) Market 2013-2018, by Type, in Volume
Table Global Vinblastinesulphate (CAS 143-67-9) Market Forecast 2019-2024, by Type, in USD Million
Table Global Vinblastinesulphate (CAS 143-67-9) Market Forecast 2019-2024, by Type, in Volume
Table Guangzhou Hanfang Pharmaceutical Overview List
Table Vinblastinesulphate (CAS 143-67-9) Business Operation of Guangzhou Hanfang Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Hainan Vinca Biological Medicine Technology Overview List
Table Vinblastinesulphate (CAS 143-67-9) Business Operation of Hainan Vinca Biological Medicine Technology (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Guangzhou Person Pharmaceutical Overview List
Table Vinblastinesulphate (CAS 143-67-9) Business Operation of Guangzhou Person Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Hainan Yueyang Biotechnology Overview List
Table Vinblastinesulphate (CAS 143-67-9) Business Operation of Hainan Yueyang Biotechnology (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Hubei Honch Pharmaceutical Overview List
Table Vinblastinesulphate (CAS 143-67-9) Business Operation of Hubei Honch Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Fine Chemicals Corporation Overview List
Table Vinblastinesulphate (CAS 143-67-9) Business Operation of Fine Chemicals Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Hengtengfu Biological Products Overview List
Table Vinblastinesulphate (CAS 143-67-9) Business Operation of Hengtengfu Biological Products (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Vinkem Overview List
Table Vinblastinesulphate (CAS 143-67-9) Business Operation of Vinkem (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Vinblastinesulphate (CAS 143-67-9) Sales Revenue 2013-2018, by Company, in USD Million
Table Global Vinblastinesulphate (CAS 143-67-9) Sales Revenue Share, by Company, in USD Million
Table Global Vinblastinesulphate (CAS 143-67-9) Sales Volume 2013-2018, by Company, in Volume
Table Global Vinblastinesulphate (CAS 143-67-9) Sales Volume Share 2013-2018, by Company, in Volume
Table Major Consumers List and Overview
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Vinblastinesulphate (CAS 143-67-9) Demand Forecast 2019-2024, by Application, in USD Million
Table Vinblastinesulphate (CAS 143-67-9) Demand Forecast 2019-2024, by Application, in Volume
Table Vinblastinesulphate (CAS 143-67-9) Production 2013-2018, by Region, in USD Million
Table Vinblastinesulphate (CAS 143-67-9) Production 2013-2018, by Region, in Volume
Table Global Vinblastinesulphate (CAS 143-67-9) Market 2013-2018, by Region, in USD Million
Table Global Vinblastinesulphate (CAS 143-67-9) Market Share 2013-2018, by Region, in USD Million
Table Global Vinblastinesulphate (CAS 143-67-9) Market 2013-2018, by Region, in Volume
Table Global Vinblastinesulphate (CAS 143-67-9) Market Share 2013-2018, by Region, in Volume
Table North America Vinblastinesulphate (CAS 143-67-9) Market Size 2013-2018, by Country, in USD Million
Table North America Vinblastinesulphate (CAS 143-67-9) Market Size 2013-2018, by Country, in Volume
Table Europe Vinblastinesulphate (CAS 143-67-9) Market Size 2013-2018, by Country, in USD Million
Table Europe Vinblastinesulphate (CAS 143-67-9) Market Size 2013-2018, by Country, in Volume
Table Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Market Size 2013-2018, by Country, in USD Million
Table Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Market Size 2013-2018, by Country, in Volume
Table South America Vinblastinesulphate (CAS 143-67-9) Market Size 2013-2018, by Country, in USD Million
Table South America Vinblastinesulphate (CAS 143-67-9) Market Size 2013-2018, by Country, in Volume
Table Middle East & Africa Vinblastinesulphate (CAS 143-67-9) Market Size 2013-2018, by Country, in USD Million
Table Middle East & Africa Vinblastinesulphate (CAS 143-67-9) Market Size 2013-2018, by Country, in Volume
Table Vinblastinesulphate (CAS 143-67-9) Market Forecast 2019-2024, by Region, in USD Million
Table Vinblastinesulphate (CAS 143-67-9) Market Forecast 2019-2024, by Region, in Volume
Table Price Factors List

List Of Figures

LIST OF FIGURES

Figure Global Vinblastinesulphate (CAS 143-67-9) Market Growth 2013-2018, by Type, in USD Million
Figure Global Vinblastinesulphate (CAS 143-67-9) Market Growth 2013-2018, by Type, in Volume
Figure North America Vinblastinesulphate (CAS 143-67-9) Market Concentration, in 2018
Figure Europe Vinblastinesulphate (CAS 143-67-9) Market Market Concentration, in 2018
Figure Asia-Pacific Vinblastinesulphate (CAS 143-67-9) MMarket Concentration, in 2018
Figure South America Vinblastinesulphate (CAS 143-67-9) Market Concentration, in 2018
Figure Middle East & Africa Vinblastinesulphate (CAS 143-67-9) Market Concentration, in 2018
Figure Vinblastinesulphate (CAS 143-67-9) Demand in Lymphoma, 2013-2018, in USD Million
Figure Vinblastinesulphate (CAS 143-67-9) Demand in Lymphoma, 2013-2018, in Volume
Figure Vinblastinesulphate (CAS 143-67-9) Demand in Lung Cancer, 2013-2018, in USD Million
Figure Vinblastinesulphate (CAS 143-67-9) Demand in Lung Cancer, 2013-2018, in Volume
Figure Vinblastinesulphate (CAS 143-67-9) Demand in Breast & Ovarian Cancer, 2013-2018, in USD Million
Figure Vinblastinesulphate (CAS 143-67-9) Demand in Breast & Ovarian Cancer, 2013-2018, in Volume
Figure Vinblastinesulphate (CAS 143-67-9) Demand in Leukemia, 2013-2018, in USD Million
Figure Vinblastinesulphate (CAS 143-67-9) Demand in Leukemia, 2013-2018, in Volume
Figure Vinblastinesulphate (CAS 143-67-9) Demand in Others, 2013-2018, in USD Million
Figure Vinblastinesulphate (CAS 143-67-9) Demand in Others, 2013-2018, in Volume
Figure North America Vinblastinesulphate (CAS 143-67-9) Market Size and Growth 2013-2018, in USD Million
Figure North America Vinblastinesulphate (CAS 143-67-9) Market Size and Growth 2013-2018, in Volume
Figure Europe Vinblastinesulphate (CAS 143-67-9) Market Size and Growth 2013-2018, in USD Million
Figure Europe Vinblastinesulphate (CAS 143-67-9) Market Size and Growth 2013-2018, in Volume
Figure Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Market Size and Growth 2013-2018, in USD Million
Figure Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Market Size and Growth 2013-2018, in Volume
Figure South America Vinblastinesulphate (CAS 143-67-9) Market Size and Growth 2013-2018, in USD Million
Figure South America Vinblastinesulphate (CAS 143-67-9) Market Size and Growth 2013-2018, in Volume
Figure Middle East & Africa Vinblastinesulphate (CAS 143-67-9) Market Size and Growth 2013-2018, in USD Million
Figure Middle East & Africa Vinblastinesulphate (CAS 143-67-9) Market Size and Growth 2013-2018, in Volume
Figure Marketing Channels Overview